Los Angeles Capital Management
OLMA icon

Los Angeles Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Los Angeles Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.75K Sell
654
-37,424
-98% -$833K ﹤0.01% 1959
2025
Q4 		$334K Buy
+38,078
New +$678K ﹤0.01% 1044

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Los Angeles Capital Management's OLMA Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 98% in Q1 2026, selling an estimated $833K and leaving 654 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Los Angeles Capital Management first reported a position in OLMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $334K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Los Angeles Capital Management held 654 shares of Olema Pharmaceuticals worth $9.75K as of Q1 2026.
  • Los Angeles Capital Management sold 37,424 Olema Pharmaceuticals shares in Q1 2026, an estimated $833K.
  • Olema Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1959 holding.
  • Los Angeles Capital Management first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Los Angeles Capital Management's Olema Pharmaceuticals position peaked at $334K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.